NCT00839423View on ClinicalTrials.gov

Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults

PHASE2CompletedINTERVENTIONAL

Enrollment

426

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

September 30, 2007

Conditions

Major Depressive Disorder

Interventions

DRUG

Placebo

capsules, daily, orally

DRUG

Vortioxetine (Lu AA21004)

encapsulated tablets, daily, orally

DRUG

Venlafaxine XL

capsules, daily, orally

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY

NCT00839423 - Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults | Biotech Hunter | Biotech Hunter